Advanced glycation end products down-regulate gap junctions in human hepatoma SKHep 1 cells via the activation of Src-dependent ERK1/2 and JNK/SAPK/AP1 signaling pathways

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 15, 2010, Pages 8636-8642

  Lin, Feng L ^a,b   Chang, Chi I ^a   Chuang, Kuo Pin ^a   Wang, Chi Y ^c   Liu, Hung J ^a,c  

^a NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b TAJEN UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Advanced glycation end products (AGEs); connexin 32; connexin 43; ERK1 2; JNK SAPK

Indexed keywords

ADVANCED GLYCATION END PRODUCTS; CONNEXIN 32; CONNEXIN 43; ERK1/2; JNK/SAPK;

BODY FLUIDS; CELL CULTURE; GROWTH KINETICS; SIGNALING;

PROTEINS;

ADVANCED GLYCATION END PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; ONCOPROTEIN; PROTEIN KINASE P60; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL JUNCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; HUMAN; LIVER CELL CARCINOMA; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GAP JUNCTIONS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; ONCOGENE PROTEIN P65(GAG-JUN); PROTO-ONCOGENE PROTEINS PP60(C-SRC); TRANSCRIPTION FACTOR AP-1;

BOVINAE;

EID: 77955676274     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf904240c     Document Type: Article

References (29)

1. Marrero, J. A. Hepatocellular carcinoma Curr. Opin. Gastroenterol. 2005, 21, 308-312
2. Komura, T.; Mizukoshi, E. Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis Am. J. Gastroenterol. 2007, 102, 1939-1946
3. Richardson, L. C.; Pollack, L. A. Therapy onsight: infuence of type II diabetes on the development, treatment and outcomes of cancer Nat. Clin. Pract. Oncol. 2005, 2, 48-53
4. Min, C.; Kang, E.; Yu, S. H.; Shinn, S. H.; Kim, Y. S. Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells Diabetes Res. Clin. Pract. 1999, 46, 197-202
5. Segretain, D.; Falk, M. M. Regulation of connexin biosynthesis, assembly, gap junction formation, and removal Biochim. Biophys. Acta 2004, 1662, 3-21
6. Yamasaki, H. Aberrant expression and function of gap junctions during carcinogenesis Environ. Health Perspect. 1991, 39, 191-197
7. Sheen, I. S.; Jeng, K. S.; Wang, P. C; Shih, S. C; Chang, W. H.; Wang, H. Y.; Chen, C. C.; Shyung, L. R. Are gap junction gene connexins 26, 32 and 43 of prognostic values in hepatocellular carcinoma? A prospective study World J. Gastroenterol. 2004, 10, 2785-2790
8. Ma, X. D.; Sui, Y. F.; Wang, W. L. Expression of gap junction genes connexin 32 and connexin 43 and their proteins in hepatocellular carcinoma and normal liver tissues World J. Gastroenterol. 2000, 6, 66-69
9. Yang, J.; Ichikawa, A.; Tsuchiya, T. A novel function of connexin 32: marked enhancement of liver function in a hepatoma cell line Biochem. Biophys. Res. Commun. 2003, 307, 80-85
10. Zhang, D.; Kneda, M.; Nakahama, K. I. Connexin 43 expression promotes malignancy of HuH7 hepatocellular carcinoma cells via the inhibition of cell-cell communicaton Cancer Lett. 2007, 252, 208-215
11. Sharovskaya, J.; Kobliakova, I.; Solomatina, N.; Kibliakov, V. Effect of some carcinogenic and non-carcinogenic polycyclic aromatic hydrocarbons on gap junction intercellular communication in hepatoma cell cultures Eur. J. Cell Biol. 2006, 85, 387-397
12. Ma, X. D.; Ma, X.; Sui, Y. F.; Wang, W. L. Expression of gap junction genes connexin 32 and connexin 43 mRNAs and proteins, and their role in hepatocarcinogenesis World J. Gastroenterol. 2002, 8, 64-68
13. Vine, A. L.; Bertram, J. S. Cancer chemoprevention by connexins Cancer Metastasis Rev. 2002, 21, 199-216
14. Trosko, J. E.; Ruch, R. J. Gap junctions as targets for cancer chemoprevention and chemotherapy Curr Drug Targets 2002, 3, 465-482
15. King, T. J.; Bertram, J. S. Connexin as targets for cancer chemoprevention and chemotherapy Biochim. Biophys. Acta 2005, 1719, 146-160
16. King, T. J.; Fukushima, L. H.; Donlon, T. A.; Hieber, A. D.; Shimabukuro, K. A.; Bertram, J. S. Correlation between growth control, neoplastic potential and endogenous connexin 43 expression in HeLa cell lines: implications for tumor progression Carcinogenesis 2000, 21, 311-315
17. Andreea, S. I.; Marieta, C.; Anca, D. AGEs and glucose levels modulate type I and III procollagen mRNA synthesis in dermal fibroblast cells culture Exp. Diabetes Res. 2008, 473-603
18. Dudley, D. T.; Pang, L.; Decker, S. J.; Bridges, A. J.; Saltiel, A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 7686-7689
19. Davies, S. P.; Reddy, H.; Caivano, M.; Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochem. J. 2000, 351, 95-105
20. Lin, P. Y.; Lee, J. W.; Liao, M. H.; Hsu, H. Y.; Chiu, S. J.; Liu, H. J.; Shih, W. L. Modulation of p53 by mitogen-activated protein kinase pathways and protein kinase C delta during avian reovirus S1133-induced apoptosis Virology 2009, 385, 323-324
21. Ji, W. T.; Lee, L. H.; Lin, F. L.; Wang, L.; Liu, H. J. AMP-activated protein kinase (AMPK) facilitates avian reovirus to induce MKK3/6 and MAPK p38 signaling that is beneficial for virus replication J. Gen. Virol. 2009, 90, 3002-3009
22. Trosko, J. E.; Chang, C. C.; Madhukar, B. V.; Klaunig, J. E. Chemical, oncogene and growth factor inhibition gap junctional intercellular communication: an integrative hypothesis of carcinogenesis Pathobiology 1990, 58, 265-278
23. Trosko, J. E.; Chang, C. C.; Madhukar, B. V. Modulation of intercellular communication during radiation and chemical carcinogenesis Radiat. Res. 1990, 123, 241-251
24. Jeong, S. H.; Habeebu, S. S. M.; Klaassen, C. D. Cadmium decreases gap junctional communication in mouse liver Toxicol. Sci. 2000, 57, 156-166
25. Yi, Z. C.; Liu, Y. Z.; Li, H. X.; Yin, Y.; Zhuang, F. Y.; Fan, Y. B.; Wang, Z. Tellimagrandin I enhances gap junctional communication and attenuates the tumor phenotype of human cervical carcinoma HeLa cells in vitro Cancer Lett. 2006, 242, 77-87
26. Trosko, J. E.; Chang, C. C. Mechanisms of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer Mutat. Res. 2007, 637, 49-55
27. Baumgartner-Parzer, S. M.; Wagner, L.; Pettermann, M.; Grillari, J.; Gessl, A.; Walfhausl, W. High glucose triggered apoptosis in cultured endothelial cells Diabetes 1995, 44, 1323-1327
28. Bierhaus, A.; Hofmann, M. A.; Ziegler, R.; Nawroth, P. P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept Cardiovasc. Res. 1998, 37, 586-600
29. Yan, S. F.; Ramasamy, R.; Naka, Y.; Schmidt, A. M. Glycation, inflammation, and RAGE Circ. Res. 2003, 93, 1159-1169